Cognition Therapeutics, Inc. (CGTX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CGTX Hot Sheet
Join SI Premium – FREE
Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
